Vitamin D Therapy to Prevent Recurrent Preeclampsia in High-Risk Pregnancies
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 146 participants.
Also called NCT07717931
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 146 participants
- Sponsor
- CMH Multan Institute of Medical Sciences
- Registry
-
NCT07717931
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Pakistan
- Registry status
- Completed
Technical summary
Registry record NCT07717931. Randomized; double masking; primary purpose prevention. Start 2025-08-01 (actual); primary completion 2026-01-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vitamin D Therapy to Prevent Recurrent Preeclampsia in High-Risk Pregnancies
- Condition
- Preeclampsia
- Intervention (Drug)
- Vitamin D (Cholecalciferol )
- Intervention (Drug)
- Placebo
- Lead sponsor
- CMH Multan Institute of Medical Sciences
Record details
- Record id
cardio:ct-nct07717931- Content hash
c4acff9d3545a97c17f9d6e0de6499ec32fffa810bc5cbca11f817c0fe3ad680